Prescription medicine

Acetyl l-tyrosine, alanine and 18 other ingredients Brand names: Trophamine

Acetyl l-tyrosine, alanine and 18 other ingredients (Trophamine) is a prescription medicine. No generic is listed in FDA's NDC Directory.

No generic listed

Check it at the source: the acetyl l-tyrosine, alanine and 18 other ingredients FDA label on DailyMed (effective August 19, 2026); every acetyl l-tyrosine, alanine and 18 other ingredients label on DailyMed.

Highlights of the record

FDA label of August 19, 2026; NDC Directory, Drugs@FDA and Orange Book, October 8, 2026

Used for

From the label: indications and usage
TrophAmine® is indicated for the nutritional support of infants (including those of low birth weight) and young pediatric patients requiring TPN via either central or peripheral infusion routes.

Forms and strengths

0.82 g/100ml / 1.4 g/100ml / 1.2 g/100ml / 0.34 g/100ml / 0.48 g/100ml / 0.42 g/100ml / 0.2 g/100ml / 0.78 g/100ml / 0.024 g/100ml / 0.48 g/100ml / 0.044 g/100ml / 0.24 g/100ml / 0.54 g/100ml / 1.2 g/100ml / 0.68 g/100ml / 0.38 g/100ml / 0.36 g/100ml / 0.32 g/100ml / 0.5 g/100ml / 0.025 g/100ml

Solution.

On the market

Generic approvals: No generic approved
Labelers listed (NDC): 1 of which 0 under generic applications, 1 under brand applications, repackagers included

Supply and safety

Pharmacy cost (NADAC): Not in the survey
Shortage (FDA): None current 1 past records
Recalls by its makers (FDA): No recall recorded
FAERS reports: 28 through July 30, 2026

What is acetyl l-tyrosine, alanine and 18 other ingredients used for?

From the label: indications and usage
TrophAmine® is indicated for the nutritional support of infants (including those of low birth weight) and young pediatric patients requiring TPN via either central or peripheral infusion routes. Parenteral nutrition with TrophAmine® is indicated to prevent nitrogen and weight loss or treat negative nitrogen balance in infants and young pediatric patients where (1) the alimentary tract, by the oral, gastrostomy, or jejunostomy route, cannot or should not be used, or adequate protein intake is not feasible by these routes; (2) gastrointestinal absorption of protein is impaired; or (3) protein requirements are substantially increased as with extensive burns. […]

FDA pharmacologic class: Amino Acid.

Source: FDA drug label (TrophAmine), B. Braun Medical Inc., effective August 19, 2026 (SPL set cb6d23ff-3ec5-445a-acbe-f88fd57949bf), via openFDA; the full label on DailyMed

Is there a generic for acetyl l-tyrosine, alanine and 18 other ingredients (Trophamine)?

No generic acetyl l-tyrosine, alanine and 18 other ingredients is approved (Drugs@FDA, October 8, 2026).

Source: Drugs@FDA, FDA NDC Directory and the Orange Book (openFDA bulk files, October 8, 2026)

Is acetyl l-tyrosine, alanine and 18 other ingredients in shortage?

No acetyl l-tyrosine, alanine and 18 other ingredients presentation is listed as limited or unavailable in the FDA Drug Shortage Database (read October 8, 2026); it keeps 1 current entry listed as available (updated September 22, 2026). ASHP keeps a separate shortage list, which can differ.

Presentation	Company	Status	Updated
TrophAmine 10%, Injection, 0.1 (NDC 0264-1933-10)	B. Braun Medical Inc.	Current	September 22, 2026

Every acetyl l-tyrosine, alanine and 18 other ingredients presentation in the FDA shortage database

Source: FDA Drug Shortage Database via openFDA, updated October 8, 2026

What do FAERS reports show for acetyl l-tyrosine, alanine and 18 other ingredients?

The FDA Adverse Event Reporting System holds 28 reports that list acetyl l-tyrosine, alanine and 18 other ingredients among the medicines taken, through July 30, 2026, each a report of something that happened, not proof the medicine caused it; 5 are coded as a death and 10 as a hospital stay. Counts follow how widely a medicine is used and watched, and they are not a measure of how risky it is.

The most reported reactions

Cholestasis9
Liver Function Test Abnormal9
Condition Aggravated (a use or a product term, not a reaction)8
Bacterial Infection4
Blood Bilirubin Increased4
Catheter Sepsis4
Bilirubin Conjugated Increased3
Disseminated Intravascular Coagulation3

Source: FDA Adverse Event Reporting System (FAERS) via openFDA, reports through July 30, 2026

What next?

Other amino acids: the pharmacologic class, with prices and generics
Acetyl l-tyrosine, alanine and 18 other ingredients side effects: the label's list beside FAERS reports
Acetyl l-tyrosine, alanine and 18 other ingredients shortage record: every presentation, company and date
Check an interaction: what two or more labels say about each other